eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 17/10/2011
PIL PRIMAXIN IV Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 21/05/2010 and displayed until 17/10/2011
Reasons for adding or updating:
  • Change to drug interactions
Updated on 06/03/2009 and displayed until 21/05/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 05/09/2008 and displayed until 06/03/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 09/07/2008 and displayed until 05/09/2008
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to packaging
  • Introduction of new pack/pack size
Updated on 30/07/2001 and displayed until 09/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   imipenem monohydrate
   cilastatin sodium